Skip to main content
AAPL-0.36%MSFT+0.84%NVDA+3.92%GOOGL-1.24%AMZN+0.73%TSM-3.68%SPCX+3.16%AVGO+2.46%META+0.61%TSLA+0.92%LLY-1.13%BRK-B-1.03%WMT-0.69%JPM-2.44%SKHY+0.35%AMD-0.17%MU+4.23%V-2.27%XOM+0.20%JNJ-1.36%MA-2.41%ASMLa-5.34%ABBV-0.59%COST-0.33%1398.HK-0.99%0700.HK-3.69%KO-0.69%CVX-0.47%PG-0.75%CSCO+0.62%0939.HK-0.84%UNH-5.42%ORCL-3.38%3988.HK-0.63%BAC-1.28%HD-2.45%GE+0.38%0857.HK-0.38%1816.HK-2.30%1288.HK-0.86%0005.HK-1.42%PM-0.85%NVS-0.67%HSBA.L-1.95%MS-1.10%INTC-0.54%AZN-0.95%AMAT-0.29%AP2d-4.07%TXN+0.56%AUDJPY-0.63%NZDJPY-0.62%AUDUSD-0.53%NZDUSD-0.49%GBPAUD+0.44%EURJPY-0.43%GBPNZD+0.43%GBPTRY+0.41%CHFJPY-0.40%CADJPY-0.35%GBPHKD+0.32%USDCHF+0.32%EURUSD-0.31%AUDCAD-0.29%GBPMXN-0.28%NZDCAD-0.27%GBPCHF+0.25%AUDCHF-0.24%EURGBP-0.24%USDCAD+0.24%EURAUD+0.22%NZDCHF-0.20%GBPJPY-0.18%EURNZD+0.18%USDTHB-0.18%GBPCAD+0.16%USDILS+0.16%USDTRY+0.16%USDJPY-0.13%USDCNH-0.11%USDDKK+0.10%NZDMXN+0.09%AUDNOK+0.09%EURCNH-0.09%CHFSGD-0.09%NZDSGD+0.08%EURSGD-0.08%CADCHF+0.07%EURCAD-0.07%SGDJPY+0.07%GBPUSD-0.06%AUDSGD+0.04%USDCOP-0.04%AUDNZD-0.04%USDMXN+0.03%GBPSGD-0.02%USDSGD+0.02%EURCHF+0.01%USDHKD+0.01%USDZAR-0.01%EURDKK0.00%CHFNOK0.00%EURNOK0.00%EURSEK0.00%EURCZK0.00%NOKJPY0.00%USDPLN0.00%GBPZAR0.00%PLNJPY0.00%USDNOK0.00%USDSEK0.00%EURHKD0.00%EURPLN0.00%EURZAR0.00%AUDDKK0.00%CHFSEK0.00%XNGUSD+0.66%GAUUSD-0.25%XAUUSD-0.25%GAGUSD-0.19%XAGUSD-0.19%XPTUSD-0.16%USOIL-0.06%HG1+0.04%COFFEE0.00%COCOA0.00%W10.00%S10.00%BTCUSD-0.06%ETHUSD+58.05%USDTUSD-0.01%XRPUSD+57.05%SOLUSD+65.46%TRXUSDT+0.99%ZECUSDT+6.64%XMRUSDT+3.18%DOGEUSD+59.04%LINKUSD+1.49%XLMUSD+2.73%BCHUSDT+1.59%LTCUSD+50.36%UNIUSD+2.32%TONUSD+63.46%SUIUSD+2.22%HBARUSDT+1.20%TAOUSDT+3.06%AAVEUSD+3.40%ONDOUSDT+1.11%ICPUSDT-8.38%DOTUSDT+1.32%WLDUSDT+2.24%ARBUSDT+0.83%INJUSDT+7.93%ATOMUSDT-0.32%STXUSDT+5.89%PYTHUSDT+2.26%TIAUSDT+0.91%FETUSDT+0.68%SEIUSDT+3.60%JUPUSDT+8.60%GRTUSDT+4.68%OPUSDT-2.36%IOTAUSDT+3.18%POLUSDT+4.29%WIFUSDT+1.17%AXSUSDT+1.71%EOSUSDT+2.67%FARTCOINUSDT-1.03%IMXUSDT+3.03%GALAUSDT-1.23%DYDXUSDT+2.54%ORDIUSDT+0.39%NOTUSDT+1.77%RONINUSDT+2.00%AAPL-0.36%MSFT+0.84%NVDA+3.92%GOOGL-1.24%AMZN+0.73%TSM-3.68%SPCX+3.16%AVGO+2.46%META+0.61%TSLA+0.92%LLY-1.13%BRK-B-1.03%WMT-0.69%JPM-2.44%SKHY+0.35%AMD-0.17%MU+4.23%V-2.27%XOM+0.20%JNJ-1.36%MA-2.41%ASMLa-5.34%ABBV-0.59%COST-0.33%1398.HK-0.99%0700.HK-3.69%KO-0.69%CVX-0.47%PG-0.75%CSCO+0.62%0939.HK-0.84%UNH-5.42%ORCL-3.38%3988.HK-0.63%BAC-1.28%HD-2.45%GE+0.38%0857.HK-0.38%1816.HK-2.30%1288.HK-0.86%0005.HK-1.42%PM-0.85%NVS-0.67%HSBA.L-1.95%MS-1.10%INTC-0.54%AZN-0.95%AMAT-0.29%AP2d-4.07%TXN+0.56%AUDJPY-0.63%NZDJPY-0.62%AUDUSD-0.53%NZDUSD-0.49%GBPAUD+0.44%EURJPY-0.43%GBPNZD+0.43%GBPTRY+0.41%CHFJPY-0.40%CADJPY-0.35%GBPHKD+0.32%USDCHF+0.32%EURUSD-0.31%AUDCAD-0.29%GBPMXN-0.28%NZDCAD-0.27%GBPCHF+0.25%AUDCHF-0.24%EURGBP-0.24%USDCAD+0.24%EURAUD+0.22%NZDCHF-0.20%GBPJPY-0.18%EURNZD+0.18%USDTHB-0.18%GBPCAD+0.16%USDILS+0.16%USDTRY+0.16%USDJPY-0.13%USDCNH-0.11%USDDKK+0.10%NZDMXN+0.09%AUDNOK+0.09%EURCNH-0.09%CHFSGD-0.09%NZDSGD+0.08%EURSGD-0.08%CADCHF+0.07%EURCAD-0.07%SGDJPY+0.07%GBPUSD-0.06%AUDSGD+0.04%USDCOP-0.04%AUDNZD-0.04%USDMXN+0.03%GBPSGD-0.02%USDSGD+0.02%EURCHF+0.01%USDHKD+0.01%USDZAR-0.01%EURDKK0.00%CHFNOK0.00%EURNOK0.00%EURSEK0.00%EURCZK0.00%NOKJPY0.00%USDPLN0.00%GBPZAR0.00%PLNJPY0.00%USDNOK0.00%USDSEK0.00%EURHKD0.00%EURPLN0.00%EURZAR0.00%AUDDKK0.00%CHFSEK0.00%XNGUSD+0.66%GAUUSD-0.25%XAUUSD-0.25%GAGUSD-0.19%XAGUSD-0.19%XPTUSD-0.16%USOIL-0.06%HG1+0.04%COFFEE0.00%COCOA0.00%W10.00%S10.00%BTCUSD-0.06%ETHUSD+58.05%USDTUSD-0.01%XRPUSD+57.05%SOLUSD+65.46%TRXUSDT+0.99%ZECUSDT+6.64%XMRUSDT+3.18%DOGEUSD+59.04%LINKUSD+1.49%XLMUSD+2.73%BCHUSDT+1.59%LTCUSD+50.36%UNIUSD+2.32%TONUSD+63.46%SUIUSD+2.22%HBARUSDT+1.20%TAOUSDT+3.06%AAVEUSD+3.40%ONDOUSDT+1.11%ICPUSDT-8.38%DOTUSDT+1.32%WLDUSDT+2.24%ARBUSDT+0.83%INJUSDT+7.93%ATOMUSDT-0.32%STXUSDT+5.89%PYTHUSDT+2.26%TIAUSDT+0.91%FETUSDT+0.68%SEIUSDT+3.60%JUPUSDT+8.60%GRTUSDT+4.68%OPUSDT-2.36%IOTAUSDT+3.18%POLUSDT+4.29%WIFUSDT+1.17%AXSUSDT+1.71%EOSUSDT+2.67%FARTCOINUSDT-1.03%IMXUSDT+3.03%GALAUSDT-1.23%DYDXUSDT+2.54%ORDIUSDT+0.39%NOTUSDT+1.77%RONINUSDT+2.00%
J&

Johnson & Johnson (JNJ)

NYSE • Healthcare

$278.7
-$3.85 (-1.4%)
Market closed

November 17, 2026 at 21:00 UTC

Open$278.99
Day Range$277.56 - $281.72
Avg. Volume (3M)7.4M
Market Cap$671.7B
P/E Ratio42.2
52 Week Range
$199.38$290.25
Next EarningsIn 69 daysJan 26, 2027

Interactive Chart

00:19:00 UTC

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$25.3B100%
Gross Profitminus cost of goods$17.3B68%
Operating Incomeminus R&D and overhead$5.8B23%
Net Incomeminus taxes and the rest$210M1%

In plain terms: out of every $100 in revenue, Johnson & Johnson keeps $1 as net profit.

Fundamentals & Financials

Revenue (TTM)
$99.3B
Net Income (TTM)
$16B
EPS (TTM)
$6.6
ROA (TTM)
8.15%
Current Ratio
1.02
Dividend Yield
0.48%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+0.7%Q2 2026$2.7
+2.1%Q3 2026$2.9
+2.8%Q4 2026$2.59
Next

Jan 26

in 69 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +2.8%

Johnson & Johnson’s adjusted EPS topped expectations while revenue came in line, based on preliminary results for the third fiscal quarter of 2026 that were reported October 13, 2026. Revenue rose 5.9% to about $25.4 billion (up from roughly $24.0 billion a year ago), with performance driven by its Innovative Medicine and MedTech franchises, while the consensus comparison showed revenue of $25.399 billion versus the $25.383 billion estimate (+0.1%, in line). Adjusted EPS of $2.59 was down 7.5% from $2.80 a year ago but topped the $2.52 estimate (+2.8%). On profitability, gross margin stood at about 73% and operating margin was roughly 25%, with gross profit of about $18.5 billion and operating income of around $6.4 billion providing most of the earnings support. For the next period, consensus calls for EPS of $2.93 on revenue of $26.423 billion.

View full earnings history

About Johnson & Johnson

Johnson & Johnson develops and sells healthcare products across pharmaceuticals and medical technology, with shares listed on the NYSE under JNJ. In FY2025 it generated $94.2 billion in revenue. The company operates in healthcare as a maker of medicines and care-delivery products for hospitals, medical professionals, and retail channels.

Name
Johnson & Johnson
CEO
Joaquin Duato
Industry
Healthcare
Year Founded
1886
Employees
141,700

Today's Snapshot

AI-generated

The day ended with JNJ 1.3% lower at 278.75, in line with a weaker sector. Trading was lighter than usual, with volume about half of its usual level. Johnson & Johnson reportedly held talks with Ollin Biosciences, a biotech company, about a possible deal.

Trading Volume

Below 10d avg (7.5M)

4.3M

vs S&P 500 Today

Inline with Market

+0.01%

Updated: November 17, 2026 at 21:10 UTC

Technical Indicators

5 Buy2 Neutral1 Sell
Johnson & Johnson shows a constructive technical picture with a clear trend component and mixed short-term momentum. The ADX above 25 indicates a meaningful trend while MACD and a positive short-term momentum reading support upside bias, even though the price sits just below the nearest 10-day averages and beneath the classic pivot near 285. Medium- and long-term moving averages remain well below the current price, underscoring broader bullish context, and volatility is moderate with an ATR around 6.8. Weak OBV tempers conviction but does not erase the trend signals. Technical takeaway: Strong Buy — trend-driven strength with short-term consolidation below the pivot.
All signals
  • EMA (5 indicators)$248.62 - $279.17
    Buy
  • RSI (14)56.43
    Neutral
  • Stochastic %K (14, 3, 3)71.44
    Neutral
  • MACD Level (12, 26)5.09
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.